Pharmacokinetic study of twice vs thrice daily dosing of sandimmun neoral in pediatric renal transplant patients - A New Formulation of Ciclosporine

By Papachristou F.   Gakis D.   Sotiriou I.   Liatsis I.   Takoudas D.   Antoniadis A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1988-1990

Elsevier

Access to resources Recommend Favorite

Long-Term Experience With Sandimmun Neoral: Results in De Novo and Stable Renal Transplant Patients After 24-Month Treatment

By German Neoral Study Group   Korn A.   Farber L.   Maibucher A.   Buchholz B.   Offermann G.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2945-2947

Elsevier

Access to resources Recommend Favorite

Mass Conversion From Sandimmun to Sandimmun Neoral: 1 1/2-Year Experience

By Huraib S.   Al Khudair W.   Selim H.   Iqbal A.   Quadri K.   Abu Romeh S.   Chaballout A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2980-2982

Elsevier

Access to resources Recommend Favorite

Abbreviated Kinetic Profiles to Estimate Exposure to CyA in Renal Allograft Recipients Treated With Sandimmun-Neoral

By Serafinowicz A.   Gaciong Z.   Majchrzak J.   Baczkowska T.   Nowacka E.   Gradowska L.   Rowinski W.   Lao M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 277-279

Elsevier

Access to resources Recommend Favorite

Comparison of Efficacy, Safety, and Tolerability of Neoral vs Sandimmun in De Novo Renal Transplant Patients Over 24 Months' Treatment

By Abendroth D.   Buchholz B.   Land W.   May G.   Wiesel M.   Farber L.   Korn A.   Maibucher A.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 275-276

Elsevier

Access to resources Recommend Favorite